BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9468592)

  • 1. The influence of theobromine on angiogenic activity and proangiogenic cytokines production of human ovarian cancer cells.
    Barcz E; Sommer E; Sokolnicka I; Gawrychowski K; Roszkowska-Purska K; Janik P; Skopinska-Rózewska E
    Oncol Rep; 1998; 5(2):517-20. PubMed ID: 9468592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine receptor antagonism causes inhibition of angiogenic activity of human ovarian cancer cells.
    Barcz E; Sommer E; Janik P; Marianowski L; Skopinska-Rózewska E
    Oncol Rep; 2000; 7(6):1285-91. PubMed ID: 11032931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymidine phosphorylase-mediated angiogenesis regulated by thymidine phosphorylase inhibitor in human ovarian cancer cells in vivo.
    Tsukagoshi S; Saga Y; Suzuki N; Fujioka A; Nakagawa F; Fukushima M; Suzuki M
    Int J Oncol; 2003 May; 22(5):961-7. PubMed ID: 12684660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGF18 as a potential biomarker in serous and mucinous ovarian tumors.
    El-Gendi S; Abdelzaher E; Mostafa MF; Sheasha GA
    Tumour Biol; 2016 Mar; 37(3):3173-83. PubMed ID: 26427667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin Reduces Angiogenesis in Serous Papillary Ovarian Carcinoma of Ethanol-Preferring Rats.
    Zonta YR; Martinez M; Camargo IC; Domeniconi RF; Lupi Júnior LA; Pinheiro PF; Reiter RJ; Martinez FE; Chuffa LG
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28398226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasohibin-2 expressed in human serous ovarian adenocarcinoma accelerates tumor growth by promoting angiogenesis.
    Takahashi Y; Koyanagi T; Suzuki Y; Saga Y; Kanomata N; Moriya T; Suzuki M; Sato Y
    Mol Cancer Res; 2012 Sep; 10(9):1135-46. PubMed ID: 22826464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
    Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
    Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-angiogenesis effect of Neferine via regulating autophagy and polarization of tumor-associated macrophages in high-grade serous ovarian carcinoma.
    Zhang Q; Li Y; Miao C; Wang Y; Xu Y; Dong R; Zhang Z; Griffin BB; Yuan C; Yan S; Yang X; Liu Z; Kong B
    Cancer Lett; 2018 Sep; 432():144-155. PubMed ID: 29879497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of purinergic receptor antagonists suramin and theobromine on tumor-induced angiogenesis in BALB/c mice.
    Gil M; Skopińska-Rózewska E; Radomska D; Demkow U; Skurzak H; Rochowska M; Beuth J; Roszkowski K
    Folia Biol (Praha); 1993; 39(2):63-8. PubMed ID: 7504997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Low-grade serous, mucinous carcinoma].
    Nakayama K; Kyo S
    Gan To Kagaku Ryoho; 2015 Feb; 42(2):179-82. PubMed ID: 25834916
    [No Abstract]   [Full Text] [Related]  

  • 11. Screening of angiogenesis inhibitors by modified tumor-induced angiogenesis (TIA) test in lung cancer.
    Skopińska-Rózewska E; Sommer E; Demkow U; Chorostowska-Wynimko J; Bałan B; Rózycka B; Barcz E; Filewska M; Mlekodaj S; Rudziński P; Seweryniak W; Caban P; Kupis W; Bogdan J; Usiekniewicz P; Gatarek J; Langfort R
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():287-96. PubMed ID: 9337546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Explorative investigation of vascular endothelial growth factor receptor expression in primary ovarian cancer and its clinical relevance.
    Wimberger P; Chebouti I; Kasimir-Bauer S; Lachmann R; Kuhlisch E; Kimmig R; Süleyman E; Kuhlmann JD
    Gynecol Oncol; 2014 Jun; 133(3):467-72. PubMed ID: 24713547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the VEGF, bFGF, aFGF and IL8 angiogenic activity in urinary bladder carcinoma, using the mice cutaneous angiogenesis test.
    Rogala E; Skopińska-Rózewska E; Sommer E; Pastewka K; Chorostowska-Wynimko J; Sokolnicka I; Kazoń M
    Anticancer Res; 2001; 21(6B):4259-63. PubMed ID: 11908679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of theobromine on induction of angiogenesis and VEGF mRNA expression in v-raf transfectants of human urothelial cells HCV-29.
    Skopinska-Rózewska E; Janik P; Przybyszewska M; Sommer E; Bialas-Chromiec B
    Int J Mol Med; 1998 Dec; 2(6):649-52. PubMed ID: 9850731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-10-mediated inhibition of angiogenesis and tumor growth in mice bearing VEGF-producing ovarian cancer.
    Kohno T; Mizukami H; Suzuki M; Saga Y; Takei Y; Shimpo M; Matsushita T; Okada T; Hanazono Y; Kume A; Sato I; Ozawa K
    Cancer Res; 2003 Aug; 63(16):5091-4. PubMed ID: 12941839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts.
    Rofstad EK; Halsør EF
    Cancer Res; 2000 Sep; 60(17):4932-8. PubMed ID: 10987309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of growth and metastasis of ovarian carcinoma by administering a drug capable of interfering with vascular endothelial growth factor activity.
    Mu J; Abe Y; Tsutsui T; Yamamoto N; Tai XG; Niwa O; Tsujimura T; Sato B; Terano H; Fujiwara H; Hamaoka T
    Jpn J Cancer Res; 1996 Sep; 87(9):963-71. PubMed ID: 8878460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Claudin-4: a potential therapeutic target in chemotherapy-resistant ovarian cancer.
    Yoshida H; Sumi T; Zhi X; Yasui T; Honda K; Ishiko O
    Anticancer Res; 2011 Apr; 31(4):1271-7. PubMed ID: 21508375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-6, secreted by human ovarian carcinoma cells, is a potent proangiogenic cytokine.
    Nilsson MB; Langley RR; Fidler IJ
    Cancer Res; 2005 Dec; 65(23):10794-800. PubMed ID: 16322225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of nuclear factor-kappaB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8.
    Huang S; Robinson JB; Deguzman A; Bucana CD; Fidler IJ
    Cancer Res; 2000 Oct; 60(19):5334-9. PubMed ID: 11034066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.